Loading...
XHKG3309
Market cap317mUSD
Dec 23, Last price  
2.00HKD
1D
2.04%
1Q
-6.10%
IPO
-72.79%
Name

C-Mer Eye Care Holdings Ltd

Chart & Performance

D1W1MN
XHKG:3309 chart
P/E
39.77
P/S
1.28
EPS
0.05
Div Yield, %
0.00%
Shrs. gr., 5y
3.57%
Rev. gr., 5y
34.98%
Revenues
1.92b
+11.09%
156,472,000198,851,000248,659,000311,228,000429,374,000576,209,000699,545,0001,112,577,0001,731,903,0001,923,964,000
Net income
62m
P
22,361,00038,357,00046,887,00040,127,00042,571,00041,435,000-6,246,00021,861,000-21,875,00061,998,000
CFO
361m
+88.24%
42,606,00050,545,00053,497,00065,483,99940,904,000140,555,000104,032,000148,414,000191,858,000361,154,000
Dividend
May 31, 20210.02 HKD/sh

Profile

C-MER Eye Care Holdings Limited, an investment holding company, provides ophthalmic services under the C-MER Dennis Lam brand name in Hong Kong and Mainland China. The company operates eye and surgery centers, and satellite clinics that provide cataract and intraocular lens implant, refractive correction, corneal and external eye disease, glaucoma, vitreo-retinal disease, oculoplastic and orbital disease, and squint and pediatric ophthalmology services. It also sells vision aid and pharmaceutical products, as well as dental services. The company was founded in 2012 and is headquartered in Central, Hong Kong. C-MER Eye Care Holdings Limited is a subsidiary of C-MER Group Limited.
URL
https://cmereye.com/
IPO date
Jan 15, 2018
Employees
2,115
Domiciled in
HK
Incorporated in
KY

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
1,923,964
11.09%
1,731,903
55.67%
1,112,577
59.04%
Cost of revenue
1,807,732
1,838,681
1,163,694
Unusual Expense (Income)
NOPBT
116,232
(106,778)
(51,117)
NOPBT Margin
6.04%
Operating Taxes
37,934
34,998
10,645
Tax Rate
32.64%
NOPAT
78,298
(141,776)
(61,762)
Net income
61,998
-383.42%
(21,875)
-200.06%
21,861
-450.00%
Dividends
(22,968)
Dividend yield
0.29%
Proceeds from repurchase of equity
(58,294)
577,737
(79,382)
BB yield
1.35%
-9.56%
1.00%
Debt
Debt current
116,533
149,335
265,480
Long-term debt
586,310
303,152
206,211
Deferred revenue
281,937
198,616
Other long-term liabilities
53,343
2,968
3,657
Net debt
(47,652)
(375,192)
(48,061)
Cash flow
Cash from operating activities
361,154
191,858
148,414
CAPEX
(115,485)
(91,227)
(129,230)
Cash from investing activities
(245,371)
(210,650)
(392,720)
Cash from financing activities
(242,877)
281,640
78,100
FCF
135,661
(136,873)
(329,826)
Balance
Cash
557,418
698,512
442,363
Long term investments
193,077
129,167
77,389
Excess cash
654,297
741,084
464,123
Stockholders' equity
350,393
295,036
250,521
Invested Capital
2,059,226
2,139,807
1,553,533
ROIC
3.73%
ROCE
4.69%
EV
Common stock shares outstanding
1,255,517
1,233,126
1,150,732
Price
3.44
-29.80%
4.90
-28.88%
6.89
20.45%
Market cap
4,318,980
-28.52%
6,042,318
-23.79%
7,928,544
25.53%
EV
4,418,800
5,799,304
7,886,496
EBITDA
337,222
116,903
97,464
EV/EBITDA
13.10
49.61
80.92
Interest
18,122
19,656
12,995
Interest/NOPBT
15.59%